Skullcapflavone II Inhibits SLC1A4‐Mediated L‐Serine Uptake and Promotes Mitochondrial Damage in Gastric Cancer
Advanced Science · 2025
DOI: 10.1002/advs.202417225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Jing Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou, 310022, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Serine, Mitochondria, Amino Acid Transport System ASC. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Healthy Zhejiang One Million People Cohort.
Abstract (Originalsprache)
Gastric cancer (GC) is one of the most lethal human malignancies worldwide. Serine metabolism is essential for meeting biosynthetic demands and regulating the redox state of GC cells. This study demonstrates that Skullcapflavone II (SkII) selectively inhibits the proliferation and metastasis of GC cells. Transcriptomic and metabolomic analyses reveal that SkII treatment significantly affects serine metabolism in GC cells, and isotope tracing experiments confirmed that SkII reduces intracellular L‐serine levels by inhibiting uptake rather than de novo synthesis. Furthermore, IHC analysis reveal significant upregulation of the L‐serine transporter SLC1A4 in GC tissues. Binding studies using PELSA, SPR, DARTS, CETSA, and MD suggest that SLC1A4 is a potential direct target of SkII. SkII‐induced disruption of serine metabolism resulted in an imbalance in GSSG/GSH, leading to increased accumulation of intracellular ROS and oxidative stress. This metabolic disruption causes mitochondrial damage, impaired energy production, and increased apoptosis in GC cells. Additionally, in vivo studies reveal that a serine and glycine deficient diet significantly enhanced the antitumor efficacy of SkII, highlighting its potential as a combinatorial therapeutic strategy. These findings provide compelling evidence that SkII is a novel candidate for targeting serine metabolism, suggesting a promising therapeutic approach for treating GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou, 310022, China.
- Zhejiang Key Lab of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer, Zhejiang Cancer Hospital, Hangzhou, 310022, China.
- School of Life Sciences, Tianjin University, Tianjin, 300072, China.
- Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou, 310022, China.
- Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou, 310022, China.
- Postgraduate training base Alliance of Wenzhou Medical University, (Zhejiang Cancer Hospital), Hangzhou, 310022, China.
ORCID-Profile: Jing Zhao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Healthy Zhejiang One Million People Cohort
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- Zhejiang Provincial Medical and Health Science and Technology Program
- Project of Chinese Medical Science and Technology Foundation of Zhejiang Province
Zitieren
APA
Zhao, J., Ma, Y. B., Xia, R. H., Jiang, Z. C., Zhou, Y., Wang, Y. N., Yang, M. Y., Dai, J. J., Zhu, T., Pan, L. B., & Yuan, L. (2025). Skullcapflavone II Inhibits SLC1A4‐Mediated L‐Serine Uptake and Promotes Mitochondrial Damage in Gastric Cancer. Advanced Science. https://doi.org/10.1002/advs.202417225
Vancouver
Zhao J, Ma YB, Xia RH, Jiang ZC, Zhou Y, Wang YN, et al. Skullcapflavone II Inhibits SLC1A4‐Mediated L‐Serine Uptake and Promotes Mitochondrial Damage in Gastric Cancer. Advanced Science. 2025. doi:10.1002/advs.202417225
BibTeX
@article{Zhao2025,
author = {Zhao, Jing and Ma, Yu-Bo and Xia, Rui-Hong and Jiang, Zheng-Chen and Zhou, Ying and Wang, Ya-Nan and Yang, Meng-Yan and Dai, Jing-Jie and Zhu, Tao and Pan, Li-Bin and Yuan, Li},
title = {Skullcapflavone II Inhibits SLC1A4‐Mediated L‐Serine Uptake and Promotes Mitochondrial Damage in Gastric Cancer},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202417225}
}
EUVIMED